Volver a Agenda
Session Chair(s)
Andrew Robertson, JD, PHD
Vice President, Head of Global Regulatory Policy and Innovation
Takeda Pharmaceuticals, United States
Learning Objective : Recognize trends in biosimilar regulatory guidances within both emerging and developed markets; Identify areas of biosimilars regulation that differ between key markets.
Speaker(s)
Biosimilars: Evolving Trends in the Global Scenario: Emerging Role of the Asia Pacific Region
Sonica Sachdeva Batra, MD
Indegene Ltd., India
Associate Vice President Enterprise Medical;Global Head- Regulatory Affairs
Interdisciplinary Perspectives on Development of Naming Standards for Biosimilar Medicines
Richard Dolinar, MD
Arizona Endocrinology Center, United States
Clinical Endocrinolist
¿Tiene una cuenta?